We do not yet know how durable the effect is after six months, how it works in people who are not obese, or whether the benefit lasts once the injections stop
Summary: Retatrutide has not been confirmed to cause joint pain, but musculoskeletal symptoms are recognised across related incretin-based therapies and should be monitored and reported during clinical trials
Tissue-specific mitochondrial functionality and mitochondrial-related gene profiles in response to maternal nutrition and one-carbon metabolite supplementation during early pregnancy in heifers
doi: 10.1038/jcbfm.2010.71 53 ConfortiLGilleyJColemanMP
We evaluated the leading L-carnitine supplements across capsule and liquid formats and ranked them by form, dose, and value
The key shift we need The question is no longer: Can patients stop GLP-1s without regaining weight? It is: Which patients can taper, how slowly, with what lifestyle support, and with what monitoring? Until trials are designed to study deprescribing strategies, weight regain after abrupt withdrawal should not be framed as inevitability